YKL-40 as a new promising prognostic marker of severity in COVID infection

Lauranne Schoneveld; Aurélie Ladang; Monique Henket; Anne Noëlle Frix; E. Cavalier; Julien Guiot; L. Schoneveld; A. Ladang; M. Henket; A. Frix; J. Guiot; A. Ancion; J. Berg; O. Bonhomme; A. Bouquegneau; C. Bovy; S. Bruls; G. Darcis; J. O. Defraigne; A. Ghuysen; A. Gilbert; V. Heinen; B. Lambermont; R. Louis; O. Malaise; M. Martin; B. Misset; M. Moutschen; D. Nguyen Dang; J. Piazza; D. Szecel; J. Szecel; H. Van Cauwenberge; C. Von Frenckell; L. Vroonen

Journal ArticleOPEN ACCESS

YKL-40 as a new promising prognostic marker of severity in COVID infection

Schoneveld L
Ladang A
Henket M
et al.

Critical Care (2021) 25(1)

DOI: 10.1186/s13054-020-03383-7

16Citations

31Readers

Author supplied keywords

COVID-19
Chitinase 3-like 1
Interstitial lung disease
SARS-CoV-2
YKL-40

Cite

CITATION STYLE

APA

Schoneveld, L., Ladang, A., Henket, M., Frix, A. N., Cavalier, E., Guiot, J., … Vroonen, L. (2021). YKL-40 as a new promising prognostic marker of severity in COVID infection. Critical Care, 25(1). https://doi.org/10.1186/s13054-020-03383-7

YKL-40 as a new promising prognostic marker of severity in COVID infection

Author supplied keywords

Cite

Register to see more suggestions